News
The strategy of rewiring the brain's stress response is rooted in two pieces of scientific literature. One is biochemical.
Researchers also found that about one-third of teens undergoing weight-loss surgery had a body mass index (BMI) of more than ...
The Ozempic maker and its peers are setting their sights on oral obesity medications to diversify their portfolios and remain ...
9h
News-Medical.Net on MSNGLP-1 weight loss drugs leave users low on key nutrients, study findsThis study assessed nutrient intake in adults using GLP-1 receptor agonists (GLP-1RAs) and found widespread deficiencies in ...
The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...
WKRN Nashville on MSN13h
Wellness Wednesdays: How GLP-1 Medication, Metabolism and Hormones Impact Weight LossThis Week’s Wellness Wednesday, we’re taking a look at a topic that crosses everyone’s mind, weight loss. There are many ...
Though Eli Lilly and Novo Nordisk have recently taken steps to make their uber-popular GLP-1 drugs more affordable for ...
Weight-loss medications and bariatric surgery have both been found effective at helping people shed excess pounds — and now a ...
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...
13h
Everyday Health on MSNZebound Beats Wegovy for Weight Loss in First Head-to-Head TrialIn a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
expert reaction to systematic review and meta- analysis on GLP-1 receptor agonists and mental health
A systematic review published in JAMA Psychiatry looks at weight loss drugs (GLP-1 receptor agonists) and mental health. Prof Stella Chan, Charlie Waller Chair in Evidence-based Psychological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results